Genome Editing Market worth $3,514.08 Million by 2019 MarketsandMarkets Presents Genome Editing Market worth $3,514.08 Million by 2019 http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

The report “Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease), & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global genome editing market along with the estimates and forecasts of the revenue and market share analysis. Browse 83 market data tables and 91 figures spread through 170 pages and in-depth TOC on “Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease), & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019" http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html   http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

Early buyers will receive 10% customization on this report.   http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

The global genome editing market is expected to reach $3,514 The global genome editing market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, growing at a CAGR of 13.75%. Increased R&D expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, and technological advancements are the primary growth drivers for this market during the forecast period (2014–2019). Moreover, increasing demand for synthetic genes, and global rise in production of genetically modified crops are also expected to drive market growth. http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

However, stringent regulatory policies and adverse public perception related to genetic research may hinder the growth of this market. http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

The global genome editing market is segmented on the basis of applications, technologies and end users. On the basis of applications, the market is segmented into cell line engineering, animal genetic engineering, plant genetic engineering, and other applications. Of these, the cell line engineering segment accounted for the largest share of the global genome editing market in 2014. On the other hand, the animal genetic engineering segment is expected to grow at the highest growth rate during the forecast period. http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

By technology, the market is divided into CRISPR, TALEN, ZNF, antisense technology, and other technologies. Of these, CRISPR will account for the largest and the fastest-growing segment of the global genome editing market by 2019. On the basis of end users, the genome editing market is categorized into biotechnology and pharmaceutical companies, academic and government research institutes, and contract research organizations (CROs). http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). North America includes Canada and the U.S.; and Asia includes China, India, Japan, and the Rest of Asia. http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

Major players of this market are GenScript USA Inc. (U. S Major players of this market are GenScript USA Inc. (U.S.), Horizon Discovery Group plc (U.K.), Integrated DNA Technologies, Inc. (U.S.), Lonza Group Ltd. (Switzerland), New England Biolabs, Inc. (U.S.), OriGene Technologies, Inc. (U.S.), Sangamo Biosciences, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), and Transposagen Biopharmaceuticals, Inc. (U.S.). http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

Magarpatta city, Hadapsar Pune, Maharashtra 411013, India Contact Us Contact: Mr. Rohan Markets and Markets UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India 1-888-600-6441 Email: sales@marketsandmarkets.com http://www.linkedin.com/company/marketsandmarkets http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html

About MarketsandMarkets MarketsandMarkets is the global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. http://www.marketsandmarkets.com/Market-Reports/genome-editing-engineering-market-231037000.html